In sarcoidosis, pulmonary and general symptoms often do not cor relate with radiographic stage and routinely performed lung function tests. Asymp tomatic muscle involvement in sarcoidosis is common, but little is known about respiratory muscle involvement The aim of this study was to investigate any rela tionships between persistent complaints and/or quality of life and respiratory mus cle strength and endurance, respectively.
Sarcoidosis is a multisystem disorder, which can affect essentially every organ of the body [1] . The parts of the body most frequently involved are the lungs, lymph nodes, skin, eyes, muscles, heart and joints, and, there fore, symptoms vary considerably. In sarcoidosis, dise ase activity does not necessarily indicate a progressive or fatal course [2] . Even though the active disease often subsides spontaneously, an indication of activity is nec essary in order to monitor the course of the disease and to guide treatment, should the clinical situation justify it [2, 3] , Whilst there is no single test that accurately reflects the progression of sarcoidosis, clinical exami nation, chest radiography and lung function tests are used to evaluate and monitor the disease process. Techniques useful in assessing the extent and severity of granuloma tous inflammation and fibrosis are: 1) serum markers, including serum angiotensin converting enzyme (sACE); 2) 67Ga scan; 3) bronchoalveolar lavage (BAL); and 4) high resolution computed tomography (HRCT) [2, 4] . When indicators of disease activity, such as radiogra phic abnormalities, lung function impairment and s ACE, return to normal, nonspecific symptoms, such as fatigue and reduced exercise tolerance, may persist.
In a previous study, we found that the quality of life measured by the Sickness Impact Profile (SIP) was re lated to the perception of complaints, but not to dise ase activity as conventionally assessed [5] , The SIP is a generic health status instrument, which is intended to measure the impact of sickness rather than to objec tively measure the presence of disease [6] . It is an indi vidual's own experience of illness perceived through its effect on daily activities, feelings and attitudes [7] .
Asymptomatic granulomatous muscle involvement in sarcoidosis has been reported with a prevalence of 50-80% [8] , whereas symptomatic muscle involvement is much less common (range 1.4-2.3%) [9] . The sympto matic involvement that has been described varies from a palpable nodular type to an acute myositis, and a chro nic myopathic type [9] [10] [11] [12] . Usually, patients present with pain, weakness and muscle atrophy [13] . Little is known, however, about the frequency of respiratory muscle involvement [14] .
The aim of this study was to investigate whether there is a relationship between persistent complaints or qual ity of life disturbance and respiratory muscle function in a population of patients with sarcoidosis. Therefore, the relationships between respiratory muscle strength, endurance time, and the SIP scores and subscores were evaluated.
Materials and methods

Subjects
Eighteen out-patients suffering from sarcoidosis, who attended the Academic Hospital Nijmegen, were studied. The diagnosis of sarcoidosis was based on consistent clinical features, together with biopsy-proven noncaseating epitheloid cell granuloma. The clinical symptoms of the respective patients varied from none (sarcoidosis detected on routine chest radiography) to more or less severe respiratory symptoms or erythema nodosum and arthralgia (i.e. Lofgren's syndrome). None of the par ticipating subjects had any significant medical history that might have influenced quality of life. Patients with significant co-morbidity were excluded.
A control group (n=18), comprising healthy employ ees of the Academic Hospital Nijmegen matched for age and gender, were used as reference for the lung function tests, respiratory muscle strength and endurance time, as well as peripheral muscle strength. A control group comprising 594 subjects from a general Dutch popula tion (mean age 43 yrs, range 18-75 yrs; 267 males (45%) and 327 females (55%)) were used as reference to com pare the SIP measurements [15] .
Study design
Initially, 26 patients with sarcoidosis were contact ed. Eight declined for various personal reasons. Eight een patients agreed to participate after giving informed consent. The questionnaires were completed under supervision of a study assistant, to avoid missing data or misunderstanding. In addition, the patients were asked about their smoking history and whether they had any of the following complaints: fatigue, dyspnoea, cough, arthralgia, or erythema nodosum.
At the time the study was performed, seven of the patients still had symptoms, most notably fatigue. Ele ven of the 18 patients had not taken corticosteroids dur ing the previous 3 months. The other seven patients were taking corticosteroids during the 3 months prior to the study, with an average prednisone dose of 5.7 mg'day_1. Five of these seven patients still had symp toms. The mean ( ± s d ) sACE level was 16.8±5.9 U L 1 (reference value <20 U*!/1)* The radiographic stage var ied from 0 to III: four patients had stage 0, two stage I, 10 stage II, and two stage III appearances. Demograp hic and clinical characteristics of the patients and the control group are summarized in table 1. 
Lung function tests
Lung function measurements included forced expira tory volume in one second (FEVi), inspiratory vital capacity (IYC) measured with a pneumotachograph, and total lung capacity (TLC) measured using a body plethysmograph (Compactbody; Jaeger, Wurzburg, Ger many). The best of three efforts was selected. All volu mes were expressed as percentages of the reference values [16] .
The transfer factor of the lung for carbon monoxide (7L,CO) was measured by the single-breath method (Masterlab; Jaeger, Wurzburg, Germany). In order to compare the 7L,co level with the quality of life scores, the values were classified into four ranges: 1) normal (>80%); 2) mild decrease (60-80%); 3) moderate decrease (40-60%); and 4) severe decrease (<40% of predicted), according to the American Medical Association classes.
Respiratory muscle strength and respiratory muscle endurance
Inspiratory and expiratory muscle strength were ass essed by measuring maximal respiratory mouth pres sures using the method of B la ck and H y a tt [17] . Maximal inspiratory mouth pressure (Pi,max) was measured at residual volume (RV), whilst maximal expiratory mouth pressure (PE,max) was measured at total lung capacity (TLC). The equipment used was a pressure transducer (model MP 45-30; Validyne Engineering Corp., Northridge CA, USA). All signals were recorded on a strip chart (type BD 31; Kipp & Zonen, Delft, The Netherlands). A needle was placed in the proximal end of the mouth piece to ensure that efforts were performed with open glottis. At least five manoeuvres were performed, until the three highest values were within 5% of each other. All subjects were seated in the upright position and were wearing a noseclip while performing the tests, and the same instructions were given to each subject by one investigator. Values are expressed in absolute terms and as percentages of predicted values according to WrLSON et al [18] .
Respiratory muscle endurance was assessed by mea suring the endurance time using a modified threshold loading device as designed by N ic k e r so n and K een s [19] . This device has an inspiratory valve, which can be occluded by a weighted plunger. The plunger can be ad justed externally so that patients must generate enough inspiratory pressure to lift the inspiratory valve and allow inspiratory flow. Expiration can be performed without any resistance. The threshold loading device was first tested and validated in healthy subjects before use. There was a very close relationship between the inspira tory pressure (Pi) generated and external weight (W) (Pl=-(0.201126xW + 7.4659); r=0.999, p<0.001; Pi in cmH20, W in g). The respiratory muscle endurance time was defined as the maximal time (in seconds) during which a subject could sustain breathing against an inspi ratory pressure load equal to 70% of his/her individual Pi,max [20] , All subjects first warmed up by breathing against an inspiratory pressure load equal to 15% of their Pi,max during 2 min. Next they were presented with their individual test load and instructed to breathe for as long as they could, until they became so tired they could not continue or until they were unable to get enough air. The test was terminated if the respiratory muscle endurance time exceeded 15 min. During the test, the inspiratory pressure was recorded constantly on the strip chart as described.
Peripheral muscle strength
Quadriceps force was measured on the nondominant side with the subject sitting, both hip and knee in 90° flexion, the ankle connected to measuring-equipment based on strain gauges. A nonstretching-band was placed around the hip to prevent the subject from lifting up whilst pulling away the lower leg. The force of the hand muscles was also measured on the nondominant side with the subject sitting, the forearm and hand in a direct line with each other and resting on a table, and the fin gers enclosing two wooden handles connected to the measuring equipment based on strain gauges. In both tests, at least three isometric contractions were perform ed until the differences were not more than 5%. Bet ween each effort there was an interval of 1 min. Values are expressed as kilogram force (kgf).
Health status questionnaire
Health status and quality of life were assessed with the SIP (Dutch version) [15, 21] , The SIP was design ed to assess sickness-related behavioural dysfunction. It provides summary scores for physical, psychosocial, and overall behavioural dysfunction, as well as sepa rate scores for 12 categories of activity. The scores are expressed as percentages of the maximal possible score of dysfunction in that particular category or set of cat egories [22] . The scores range between 0 and 100. The higher the scores, the stronger the impact of the disease on the individual's life.
Statistical analysis
The data of the control subjects and patients were compared using Student's t-test for binomial values and Chi-squared test for ordinal values. Differences in per sonal characteristics were assessed using Chi-squared tests for categorical data and Student's t-tests for con tinuous data. Correlation among variables was assessed by single regression analysis. Because of the large num ber of correlations examined, a p-value of less than 0.01 was considered to be statistically significant. All ana lyses were performed using the Statistical Package for Social Sciences (SSPS).
Results
Tables 2 and 3 summarize the results of the SIP scor es, and the lung function tests, respiratory and periphe ral muscle strength assessments, respectively.
The total SIP scores for the patient group were sig nificantly higher compared with the control subjects. In 1 (3.4)  1.0 (3.2 the patients with sarcoidosis, the subscores were signi ficantly higher in the subscales "alertness behaviour", "home management", ''recreation and pastimes", "sleep and rest", ''social interaction" and "employment" (table   2>' Only one of the 18 patients had a slightly decreased 7L,CO. The absolute values for FEVi as well as FEVl % pred were within the normal range for all patients, as also were the VC and TLC. However, FEVl % pred was lower in the patients than in the control subjects The respiratory muscle endurance time correlated with the SIP subscales "mobility" (p<0.01) and "body care and movement" (pcO.OOl). However, no correlations were found between the SIP scores and Pi,max, PE,max and peripheral muscle strength, respectively (table 4) . Pati ents with symptoms (n=7) (table 1) showed lower Pl,max (p<0.03) and respiratory muscle endurance time (p<0.005), while patients who experienced fatigue (n=6) had a low er PE,max (p<0.03) compared to those without com plaints.
The radiographic stage was related to the SIP sub scales "alertness behaviour" (p<0.001), "emotional be haviour" (pcO.OOl), "home management" (p<0.005) and "social interaction" (pcO.OOl). The duration of disease, the FEVl, and the sACE levels showed no relationship with percentile scores of any of the subscales. Further more, no relationship between radiographic stage, sACE, respiratory muscle strength, and respiratory muscle endurance time were found.
Discussion
This study has shown that respiratory muscle stren gth and respiratory muscle endurance are reduced in patients with sarcoidosis. Patients with the symptom of fatigue had significantly lower maximum expiratory pressures than those without symptoms. A decreased respiratory muscle endurance time suggests the pres ence of respiratory muscle fatigue. Muscle fatigue has been defined as a condition in which there is a reduc tion in the capacity for developing force and/or veloc ity of a muscle in response to a load, and is reversible by rest [23] . In general, muscle fatigue occurs when ever energy demand exceeds energy supply [24] . Applying this to respiratory muscles, fatigue occurs when these muscles work under conditions where there is an imbal ance between energy demand and supply [24] .
Muscle weakness is a condition in which the capac ity for a rested muscle to generate force is decreased [23] . In our patient group, we found decreased Pi,max and PE,max, which indicates inspiratory as well as expira tory muscle weakness. Previously, reduced respiratory muscle strength in sarcoidosis was reported by B a y d u r et a l [13] , who compared untreated patients suffering from sarcoidosis with control subjects, and found a de crease in maximal mouth pressures (Pi,max) in the sarcoi dosis patients. In agreement with this, B a d r and S h a rm a [14] found respiratory muscle dysfunction in 61% of a group of sarcoidosis patients. Moreover, in their study, the PE,max was significantly lower than in normal con trols [14] .
The results of the present and previous studies, there fore, suggest that Pi,max and Pe,max are related to func tional impairment due to sarcoidosis. These results also emphasize the need for an integrative approach in the assessment and therapeutic management of sarcoidosis. It should be noted, however, that the respiratory mus cle tests applied in the present study depend on the co operation of the patient. To the best of our knowledge, nonvolitional tests of respiratory muscle function, such as magnetic or electrical stimulation of the phrenic ner ves, have not been reported in these patients.
Inspiratory muscles are the major muscle groups used in supporting the ventilatory demands of exercise, and the effort required to drive the inspiratory muscles dur ing exercise is a major contributor to the sensation of exertional dyspnoea [25] . With weak muscles, greater utilization of the available muscle mass is required to maintain a given external power output, resulting in an increased sense of effort. As a consequence, in persons with weak respiratory muscles, intolerable exertional discomfort and exertional dyspnoea occur at lower power outputs than in those with strong muscles [25] . In the present study, patients with symptoms had a decreased inspiratory muscle strength and endurance time, when compared to those without symptoms. The complaint of "fatigue" was associated with a lower expiratory mus cle strength. Moreover, a relationship was found bet ween the Pi,max and respiratory muscle endurance time. Thus, reduced respiratory muscle strength in the pres ence of sarcoidosis may contribute to exercise intoler ance independent of impairment in ventilatory function. This conclusion is consistent with that of H a m il t o n et a l [25] , who showed that in patients with cardio respiratory disorders, respiratory, as well as peripheral, muscle strength was a significant contributor to symp tom intensity and work capacity, in addition to any con tribution from ventilatory, gas exchange, and circulatory impairment.
Several factors, such as hypoxaemia, hypercapnia, malnutrition, decreased blood supply to the muscles, drugs, and electrolyte abnormalities, contribute to res piratory muscle weakness and fatigue, e.g. in chronic obstructive pulmonary disease patients [26, 27] ; how ever, these are unlikely to contribute in sarcoidosis. Which factor or combination of factors is responsible for this effect in sarcoidosis has not yet been established. In the absence of metabolic abnormalities, recent data have emphasized the role of inflammatory products on diff erent aspects of muscle metabolism. As in other immunemediated disorders, most clinical manifestations of sarcoidosis are secondary to the direct effect of the ac cumulation of activated immunocompetent cells in the involved tissues, notably helper T-lymphocytes and mac rophages, and by an increased production of different cytokines [28, 29] . These cytokines appear to be pro duced in inflamed lesions of sarcoidosis and released into the bloodstream [30] . Future identification of these products could lead to specific therapeutic interventions aimed at blocking their effect in the clinical manage ment of patients with inflammatory disorders, such as sarcoidosis.
As previously suggested, impaired respiratory muscle function suggests that the respiratory muscles can be involved in the granulomatous process of sarcoidosis [13] . Many reports have described granulomatous myopathy without overt manifestations of sarcoidosis elsewhere; sometimes a past history of sarcoidosis was suggested. Hence, granulomas in muscles may persist after those in other organs have become inactive or have resolved in patients who have passed through the active gener alized stages of sarcoidosis without obvious symptoms [31] . Little is known about involvement of respiratory muscles, as only a few cases have been described [14, 32, 33] , For example, it is not known whether diap hragm and/or intercostal muscle involvement in sar coidosis is a possible contributory factor to dyspnoea or impairment of vital capacity [31] . However, histologi cal confirmation of respiratory muscle involvement is hard to obtain. Furthermore, myopathy, including disor ders of the respiratory muscles, is a well-known sideeffect of corticosteroids [34, 35] , It should be considered especially with higher doses of steroids, in the presence of markedly impaired respiratory muscle strength or con tinuous treatment with fiuorinated steroids [36] . In the present group of patients, only seven had been treated with steroids during the 3 months prior to the study and the doses they received were low. Moreover, the respi ratory and peripheral muscle strength did not differ between patients with or without a history of corticos teroid treatment.
The TL.CO is considered by some authors to be the most sensitive index of lung function in sarcoidosis. It is often the first or only index to be decreased [14] . Remarkably, however, in the present study the respi ratory muscle force and endurance were significantly lower than in the control group, even though other lung function tests were normal. This suggests that maximal mouth pressure and respiratory muscle endurance time may be more sensitive to functional impairment due to sarcoidosis than are the 7lL,CO or VC, which have been suggested as the best indices to correlate with working capacity [37] . The relationship between radiographic stage, lung function and exercise abnormality have, how ever, been variable [38] . Clearly, there is a wide spectrum of tissue inflammation and organ dysfunction within, as well as between, each radiographic stage. K a r e t z k y and M c D o n o u g h [38] found that the magnitude of func tional impairment may vary widely from the apparent histopathological involvement as reflected by chest radiography and lung volumes. In the present study, we found a relationship between the radiographic stage and impairment in the fields "alertness behaviour", "emo tional behaviour", "home management" and "social inter action".
Furthermore, in the present study, the SIP subscales "mobility" and "body care and movement" as well as the presence of symptoms were shown to correlate with res piratory muscle endurance time. However, for both of these latter domains there was no difference between patients and the control subjects. Moreover, our results show that patients with sarcoidosis are limited in phy sical and psychosocial functioning. They appear to be particularly affected in the fields "sleep and rest", "re creation and pastime", "employment", "alertness beha viour", "home management" and "social interaction", compared to a control group [15] . This diversity illustra tes the broad impact of sarcoidosis on patients' quality of life.
In conclusion, respiratory muscle strength and endu rance are reduced in patients with sarcoidosis. Decreas ed respiratory muscle endurance was found to be related particularly to the Sickness Impact Profile subscales "mobility" and "body care and movement". However, no such relationship was found between these latter Sick ness Impact Profile subscales and routinely performed lung function tests, such as transfer factor and spirom etry. Measuring respiratory muscle function seems to quantify and characterize the functional impairment in patients with sarcoidosis and reflects symptoms, such as fatigue and general weakness, that are otherwise dif ficult to assess objectively. Therefore, we suggest that measurements of respiratory muscle strength and endu rance time could be usefully included in the diagnostic work-up and follow-up of patients with sarcoidosis. Fur ther studies are needed to assess respiratory and peri pheral muscle involvement, as well as the relationship with the presence of inflammatory characteristics in sar coidosis.
